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1078–5884/00Relative Tolerance to Upper- and Lower-Limb Aerobic
Exercise in Patients with Peripheral Arterial Disease
I. Zwierska,1 R.D. Walker,2 S.A. Choksy,2 J.S. Male,1 A.G. Pockley2 and J.M. Saxton1*1The Centre for Sport and Exercise Science, Sheffield Hallam University, Collegiate Crescent Campus, Sheffield
S10 2BP, and 2Division of Clinical Sciences (North), University of Sheffield, Northern General Hospital,
Herries Road, Sheffield S5 7AU, UKObjectives. To investigate the effects of peripheral arterial disease (PAD) on relative tolerance to upper- and lower-limb
aerobic exercise.
Methods. Peak cardiorespiratory responses evoked by an incremental arm-cranking test (ACT) and an incremental leg-
cranking test (LCT) were compared in patients with PAD (NZ101; median age 69 year, range 50–85 years). Claudication
distance (CD) and total distance before intolerable claudication pain (maximum walking distance: MWD) were also assessed
during walking.
Results. Peak oxygen consumption ð _VO2Þ for the ACT was 94% of that measured for the LCT (1.01G0.03 versus 1.10G
0.03 l minK1, respectively; P!0.001), but in a significant proportion of patients (35%; P!0.001), exceeded that recorded
for the LCT. The ratio of upper- to lower-limb peak _VO2 was higher (0.98G0.04 compared to 0.98G0.05 l min
K1 and
1.00G0.06 compared to 1.21G0.06 l minK1; P!0.01), whereas walking performance (CD: 94G14 versus 187G25 m,
P!0.01; MWD: 227G20 versus 394G33 m, P!0.01) was lower for patients in the lowest ankle to brachial pressure index
quartile compared to patients in the highest quartile, respectively.
Conclusion. Upper-limb aerobic conditioning could be a useful exercise stimulus for maintaining or improving
cardiorespiratory function in patients with severe PAD as they have a greater relative upper-limb aerobic power.Keywords: Intermittent claudication; Upper-limb exercise.Introduction
The prevalence of peripheral arterial disease (PAD)
increases with advancing age and it has been
estimated that almost 20% of people over the age
of 70 years have the condition.1 In the UK, the
number of people aged 65 and over is expected to
increase at 10 times the overall rate of population
growth in the next 40 years,2 which means that the
prevalence of PAD and its sequelae can be
expected to increase.
Exercise rehabilitation is a relatively inexpensive
alternative to pharmacological or surgical treatments
for symptomatic PAD, which is usually manifest as
intermittent claudication (IC), and is used as a
conservative treatment approach where possible. In
accordance with the principle of exercise specificity,
most exercise rehabilitation programs have involvedng author. Dr John M. Saxton, PhD, The Centre for
ercise Science, Sheffield Hallam University, Collegiate
pus, Sheffield, South Yorkshire S10 2BP, UK.
: j.m.saxton@shu.ac.uk
0157 + 07 $35.00/0 q 2005 Elsevier Ltd. All rights reserthe lower-limbs and have included some form of
walking exercise.3 However, the degree of ischemic
pain evoked by walking could deter some patients
from engaging in lower-limb exercise rehabilitation.
Symptomatic arterial insufficiency of the upper-limbs
is over 20 times less frequent than lower-limb arterial
occlusion in patients with PAD.4,5 As a result, patients
with IC are less likely to experience ischemic pain
during arm exercise which can severely limit walking
exercise.
In healthy young and older individuals, peak
upper-limb aerobic power is generally in the region
of 70% of that measured for the lower-limbs due to the
smaller amount of active skeletal muscle.6–12 However,
Fardy et al.13 reported the case of a patient with IC
whose maximal exercise capacity for upper-limb
aerobic exercise (arm-cranking) was equivalent to
that for treadmill walking, as a consequence of the
impaired lower-limb perfusion and ischemic pain
encountered during lower-limb exertion. This finding
was recently supported by a study of 10 patients
with PAD, whose peak exercise capacity duringEur J Vasc Endovasc Surg 31, 157–163 (2006)
doi:10.1016/j.ejvs.2005.06.025, available online at http://www.sciencedirect.com onved.
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during treadmill walking.14 As cardiorespiratory
adaptations occur in proportion to the absolute values
for oxygen consumption ð _VO2Þ, cardiac output or
stroke volume attained during exercise training,15
these studies suggest that upper-limb aerobic exercise
could be an equivalent exercise stimulus for main-
taining or improving cardiorespiratory function in
patients with PAD.
Preliminary evidence from our laboratory showed
that upper-limb aerobic exercise training (arm-
cranking) is well-tolerated in patients with PAD
and that it can induce improvements in cardio-
vascular function and walking ability.16 Improved
knowledge about tolerance to alternative exercise
modalities such as arm-cranking could have import-
ant implications for exercise prescription in this
patient group. Thus, the aim of this study was to
investigate the effects of PAD on relative tolerance to
upper- and lower-limb aerobic exercise in a large
heterogeneous group of patients with stable IC. We
hypothesized that patients with greater PAD sever-
ity, as indicated by established haemodynamic
parameters, would have a higher relative aerobic
arm exercise capacity than patients with less severe
disease pathology.Materials and MethodsPatient recruitment
A total of 101 patients (median age 69 year, range 50–
85 years) with stable IC were recruited from the
Sheffield Vascular Institute at the Northern General
Hospital, Sheffield, UK. The clinical diagnosis of IC
was established using the patient’s history and a
physical examination, and was confirmed by the
Doppler assessment of ankle-brachial pressure index
(ABPI), a non-invasive reliable measure of lower-
extremity haemodynamics,17 in accordance with
current UK medical practice. The resting ABPI in the
symptomatic leg of most patients with intermittent
claudication is reduced,18 and a value of less than 0.90
is 95% sensitive and 99% specific for PAD19 and
supports the diagnosis of peripheral arterial insuffi-
ciency.18 Six patients had an ABPI of R0.9 which
showed a clinically important decrease of at least 0.15
after maximal walking exercise,20 and these were,
therefore, included in the analyses. The absence of
significant upper extremity arterial disease was
confirmed by pulse examination and brachial artery
systolic pressures that were within 10 mmHg of eachEur J Vasc Endovasc Surg Vol 31, 2 2006other.17 The mean G SE brachial artery pressures for
the left and right arms were 156G2 and 153G
2 mmHg, respectively. Patients experiencing symp-
toms of IC for less than 12 months, or reporting a
significant change in walking ability within this time
period were considered to have unstable disease and
were, as a consequence, excluded. Patients were also
excluded if they exhibited features of critical ischemia,
had undergone a re-vascularization procedure within
the previous 12 months, or if initial assessment
established that they suffered from severe arthritis or
unstable cardiorespiratory conditions such as short-
ness of breath during physical exertion or exercise-
limiting angina. Patients on long-term medication
continued with their treatment. Demographic data
(sex, age, weight, height, body mass index, diabetic,
hypertension and smoking status) are shown in
Table 1. Ethical approval was obtained from the
North Sheffield Local Research Ethics Committee
and all patients provided informed consent before
entering the study.Assessment of upper- and lower-limb aerobic exercise
tolerance
Patients were instructed not to perform any
vigorous exercise in the 24 h before the exercise
assessments, and to abstain from caffeinated bev-
erages and nicotine intake for at least 2 h prior to
each test. After familiarization with the test
protocols, patients performed an incremental arm-
cranking test (ACT) and an incremental leg-cranking
test (LCT) on separate occasions, with the order of the
tests being randomized. A calibrated electronically-
braked cycle ergometer (modified for arm-cranking)
was used for both tests (Gould, Bilthoven, Holland).
For the ACT, the mid-point of the sprocket was set at
shoulder height and for the LCT, the seat height was
adjusted to allow slight knee flexion at bottom dead
centre.
The ACT and LCT were performed at a similar time
of the day and were discontinuous in nature,
comprising 3-min bouts of constant work at a cranking
rate of 50 rev minK1 interpolated with 2-min rest
intervals, to maximum exercise tolerance. The initial
intensity was 9 W for both tests, with power output
being increased by 7 and 14 W per increment in the
ACT and LCT, respectively. Prior to each assessment,
resting blood pressure and heart rate were recorded
and a small (25 ml) blood sample was taken from
a finger-tip for blood lactate analysis (YSI 1500
Sport, Ohio, USA). During each work increment,
pulmonary gas exchange variables were measured
Table 1. Demographics, haemodynamic and walking performance
data for the patient cohort
Variable
N 101
Sex
Male(%) 79
Female(%) 21
Median age, years (range) 69 (50–85)
Weight (kg) 78.3G1.5
Height (m) 1.68G0.01
Body mass index (kg mK2) 27.6G0.44
Diabetes mellitus (%) 18
Beta-receptor antagonist medication (%) 26
Smoking status
Current (%) 32
Previous (%) 62
Never smoked (%) 6
Resting ABPI 0.65G0.02
CD (incremental shuttle-walk test) (m) 133G10
MWD (incremental shuttle-walk test) (m) 321G15
ABPI data are presented for the most symptomatic limb. Patients
with diabetes mellitus were taking oral hypoglycemics or insulin.
Unless otherwise stated, values are means G SE.
Upper- and Lower-Limb Exercise in Claudicants 159breath-by-breath (CaSE EX670 PulmoLab, Kent, UK)
and heart rate (HR) was continuously monitored using
a 6-lead ECG (Marquette CaSE 15, Wisconsin, USA).
Pulmonary variables, which were averaged from the
last 30 s of each work increment, included _VO2, carbon
dioxide production ð _VCO2Þ, respiratory exchange
ratio ðRER : _VCO2= _VO2Þ, pulmonary ventilation
ð _VEÞ, tidal volume (Vt) and breath frequency (Bf).
Perceived exertion using the Borg RPE 15-graded
scale21 and the degree of pain experienced using the
Borg CR-10 scale21 were also recorded during the last
30 s of each work increment. Systolic (SBP) and
diastolic (DBP) blood pressure readings (manual
sphygmomanometer) and a finger-tip blood sample
for blood lactate analysis were obtained immediately
after each work increment. The rate-pressure product
(RPP), an index of myocardial workload,22,23 was
calculated for each work increment as the product of
HR and SBP. After reaching maximum exercise
tolerance, patients rested on a chair and were
monitored until complete recovery.Assessment of walking performance
Walking ability was assessed using an incremental
shuttle-walk test as previously described,24 which has
similar test-retest reproducibility as standardized
treadmill testing. Briefly, the test involves the patient
walking back and forth between two cones placed
10 m apart on a flat floor, with walking speed being
controlled by bleeps recorded onto an audio-tape. The
initial walking speed for the test is 3 km hK1 and thereis a step-increase in walking speed of 0.5 km hK1 every
minute. Distance to the onset of claudication pain
(claudication distance, CD) and the maximum walk-
ing distance (MWD) before intolerable claudication
pain were recorded.Statistical analysis
Dependent variables were tested for normal distri-
bution using the Kolmogorov–Smirov goodness of fit
test. On the whole, peak physiological responses for
the ACT and LCT were normally distributed and
compared using the paired t-test. Non-parametric
responses (RPE and CR-10) were compared using the
Wilcoxon signed ranks test, and the Mann–Whitney U-
test was used to compare relative aerobic arm exercise
capacity (ratio of upper- to lower-limb peak _VO2) and
walking performance between patients in the lowest
and highest quartiles for resting ABPI in the most
symptomatic leg. Differences were detected using
Bonferroni-adjusted alpha levels. Patients on beta-
receptor antagonist medication were included in the
analysis, as exclusion of their data had no effect on the
results for cardiorespiratory variables, perceived
exertion or pain. All statistical analyses were per-
formed using SPSS for Windows (SPSS UK Ltd,
Woking, UK). The results are expressed as means G
SE unless otherwise stated.Results
Peak _VO2 for the ACT was 94% of that measured
for the LCT (P!0.001), representing an absolute
difference between upper- and lower-limb
aerobic exercise capacity of less than 0.10 l minK1
(1.1 ml kg minK1) (Table 2). Peak power output for
the ACT was 65% of that achieved in the LCT (P!
0.001). Peak values for _VCO2 (P!0.001) and Vt (P!
0.001) were also lower for arm-cranking exercise, but
no differences in the peak measures of RER, _VE, Bf,
HR, SBP, RPP or RPE between the ACT and LCT
were observed. Patients experienced a higher level of
leg pain during the LCT than arm pain during the
ACT at maximum exercise tolerance (‘very strong’
versus ‘moderate to strong’; P!0.001), despite
similar RPE and blood lactate levels being observed
during arm-cranking (Table 2). In over one-third of
the patients (35%), peak upper-limb aerobic capacity
was equal to or exceeded lower-limb aerobic exercise
capacity, with mean values of 1.10G0.04 versus
0.96G0.05 l minK1 (14.2G0.51 versus 12.4G
0.51 ml kg minK1), respectively (P!0.001).Eur J Vasc Endovasc Surg Vol 31, 2 2006
Table 2. Cardiorespiratory, metabolic, perceived exertion and pain responses at maximum exercise tolerance during the ACT and LCT
Variable ACT LCT
Power output (W) 44 (42–47) 68 (63–72)**
_VO2 (l min
K1) 1.01 (0.96–1.06) 1.10 (1.04–1.16)**
_VO2 (ml kg min
K1) 13.1 (12.5–13.7) 14.2 (13.5–14.9)**
_VCO2(l min
K1) 0.98 (0.92–1.03) 1.07 (1.00–1.12)**
RER ð _VCO2= _VO2Þ 0.99 (0.97–1.02) 0.99 (0.97–1.01)
_VE (l minK1) 35.8 (33.6–37.9) 37.5 (35.4–39.6)
Vt (l) 1.25 (1.18–1.32) 1.36 (1.28–1.43)**
Bf (breaths minK1) 30.1 (29.0–31.2) 29.4 (28.3–30.6)
SBP (mmHg) 194 (189–199) 199 (193–205)
DBP (mmHg) 92 (90–94) 90 (88–92)
HR (beats minK1) 114 (110–119) 113 (109–117)
Rate pressure product (HR!SBP) 22,322 (21,151–23,494) 22,608 (21,390–23,828)
Blood lactate concentration, mM 3.27 (3.05–3.50) 3.09 (2.89–3.28)
Perceived exertion 17 (16.8–17.2) 17 (16.4–17.4)
Perceived pain 4.5 (3.8–5.2) 6.8 (6.3–7.3)**
Values are means with 95% confidence intervals in parentheses. ** P!0.001 between the ACT and LCT.
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PAD exhibited a greater relative upper-limb aerobic
exercise capacity than patients with less severe
disease, the ratio of peak _VO2 recorded during the
ACT to that recorded during the LCT in the lowest
and highest ABPI quartiles for the most sympto-
matic leg were compared. Patients in the lowest
ABPI quartile had a mean resting ABPI of 0.43
(range 0.27–0.53) in comparison to a mean resting
ABPI of 0.86 (range 0.78–0.99) for patients in the
highest ABPI quartile. The ratio of upper- to lower-
limb aerobic exercise capacity was 1.00G0.05
(0.98G0.04 compared to 0.98G0.05 l minK1) for
patients in the lowest ABPI quartile and 0.83G
0.02 (1.00G0.06 compared to 1.21G0.06 l minK1;
P!0.01) for patients in the highest ABPI quartile
(P!0.01), thereby indicating a greater relative
upper-limb exercise capacity in patients with
increased disease severity (Fig. 1).
In addition, 62% of patients in the lowest ABPI
quartile exhibited an upper-limb aerobic exercise
capacity which was R90% of that measured for the
lower-limbs, in comparison to only 17% of patients
in the highest ABPI quartile. Patients in the lowest
ABPI quartile also claudicated sooner and had a
lower MWD than those in the highest quartile (CD,
94G14 versus 187G25 m; PZ0.002; MWD, 227G20
versus 394G33 m; P!0.001; Fig. 1). These results
show that patients in the lowest ABPI quartile had
much poorer walking ability, with CD and MWD
being only 50 and 58% of the respective distances
measured for patients in the highest ABPI quartile.
Scatterplot and bivariate regression analysis
showed that ABPI was significantly correlated
with the ratio of upper- to lower-limb aerobic
exercise capacity (rZK0.34; P!0.01. Fig. 2).Eur J Vasc Endovasc Surg Vol 31, 2 2006Discussion
This is the first study to compare indices of
cardiorespiratory and metabolic stress, perceived
exertion and exercise-induced pain in comparable
forms of incremental upper- and lower-limb aerobic
exercise in a large heterogeneous cohort of patients
with stable IC. Our results show that in this large
cohort of patients, peak _VO2 for the ACT was 94% of
that measured for the LCT, representing an absolute
difference of less than 0.10 l minK1 (1.1 ml kg minK1)
between upper- and lower-limb aerobic exercise
capacity. This supports the findings of Fardy et al.,13
who reported a similar aerobic exercise capacity
between incremental arm-cranking exercise and tread-
mill walking in a single patient with intermittent
claudication. Our values for peak _VO2 are also within
1–2 ml kg minK1 of those recently reported for 10
patients with PAD who underwent incremental arm-
cranking and treadmill testing to maximum exercise
tolerance.14 Although our study measured lower-limb
exercise capacity using leg-cranking exercise, the peak
cardiorespiratory responses evoked by leg-cranking
have recently been shown to be equivalent to those
evoked by incremental treadmill walking in this
patient group.25
Peak _VO2 for arm-cranking exercise, expressed as a
percentage of peak _VO2 for leg-cranking exercise is
typically around 70% in healthy young and older
individuals, with a range of 46–88% being reported in
different studies.6–12 Other peak cardiovascular and
metabolic stress responses, such as HR,6,7,10–12 _VE7,9–12
and blood lactate concentration7,8,10 are also lower in
healthy individuals for upper-limb exertion than for
lower-limb exertion at maximum exercise tolerance.
However, peak responses for HR, SBP, RPP, RER, _VE,
Fig. 1. Ratio of upper- to lower-limb exercise capacity, CD
and MWD for the lowest and highest ABPI quartiles (most
symptomatic leg). Values are means with error bars
representing 95% confidence intervals. ** P!0.001 for the
ratio of upper- to lower-limb exercise capacity and MWD
between the lowest and highest ABPI quartiles and PZ0.002
for CD between the lowest and highest ABPI quartiles.
Fig. 2. Scatterplot of ABPI versus the ratio of upper- to lower-
limb aerobic exercise capacity.
Upper- and Lower-Limb Exercise in Claudicants 161Bf and blood lactate following incremental upper- and
lower-limb exercise were equivalent in our cohort of
patients with PAD, suggesting upper-limb aerobic
exercise could be an equivalent stimulus for evoking
cardiorespiratory adaptations. These results reflect the
impact of impaired perfusion and ischemic pain on theability to support moderate to high intensity leg
exercise in this patient group.13 This is supported by
the level of leg pain experienced at maximal exercise
intensity in the LCT, which was greater than the level
of arm pain experienced in the ACT, despite similar
levels of perceived exertion and blood lactate levels
induced by ACT. Patients typically experienced
ischemic pain in the calf and thigh regions of the
lower extremity during the LCT, which was described
as being similar to the pain experienced during
walking. Given that upper extremity arterial disease
is much less common than lower extremity involve-
ment,4,5 the pain experienced in the arms during the
ACT was more likely attributable to the fatiguing
effects of unaccustomed exercise in upper extremity
muscle groups.
Patients in the lowest ABPI quartile exhibited a
higher relative arm aerobic exercise capacity and
much poorer walking ability than patients in the
highest ABPI quartile. These results demonstrate that
disease severity has a significant impact on relative
tolerance to upper- and lower-limb aerobic exercise in
this patient group. Although patients with increased
disease severity perform more poorly on tests of
lower-limb physical function (as expected), their
ability to tolerate upper-limb aerobic exercise is well-
maintained, as demonstrated by similar peak _VO2
responses induced by ACT in the lowest and highest
ABPI quartiles (results not shown). The higher relative
upper-limb aerobic exercise capacity in patients with
more severe disease suggests that upper-limb aerobic
conditioning could be a superior exercise stimulus forEur J Vasc Endovasc Surg Vol 31, 2 2006
I. Zwierska et al.162maintaining or improving cardiorespiratory function
in patients with more severe PAD. Preliminary
evidence from our laboratory has shown that upper-
limb aerobic exercise is a good exercise stimulus for
inducing improved cardiovascular function and walk-
ing ability in patients with symptomatic PAD.16
However, whether or not patients with increased
PAD severity can gain an increased benefit from
upper-limb aerobic conditioning needs to be con-
firmed by appropriately designed exercise interven-
tion studies.Conclusion
A significant proportion of patients do not engage in
walking exercise and there is evidence that self-
reported walking ability declines at the rate of 9.2
yards per year.26,27 Alternative exercise modalities
such as arm-cranking, that prevent the ischemic pain
associated with lower-limb exercise, might help
some patients with PAD to overcome the barriers
to conventional forms of exercise rehabilitation (i.e.
walking exercise). Our results show that the differ-
ence between upper- and lower-limb peak aerobic
power in patients with PAD is minimal and that a
significant proportion of patients (particularly those
in the lowest ABPI quartile) exceed their lower-limb
peak aerobic power during upper-limb exercise. This
suggests that upper-limb aerobic conditioning could
be a useful exercise stimulus for maintaining or
improving cardiorespiratory function in patients
with severe PAD who might be more inclined to
have an aversion to painful lower-limb exercise.
Many patients with PAD have evidence of more
widespread cardiovascular conditions such as cor-
onary heart disease and hypertension and an
improvement in cardiovascular function evoked by
aerobic exercise training would also benefit patients
with these conditions. However, further research,
including well-controlled exercise intervention
studies is required, before the true potential of
upper-limb aerobic conditioning as an alternative
exercise rehabilitation strategy to lower-limb exer-
cise can be properly evaluated.Acknowledgements
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